53.24
0.74 (1.42%)
| Penutupan Terdahulu | 52.49 |
| Buka | 52.85 |
| Jumlah Dagangan | 522,983 |
| Purata Dagangan (3B) | 1,034,127 |
| Modal Pasaran | 2,922,164,992 |
| Harga / Jualan (P/S) | 11.19 |
| Harga / Buku (P/B) | 7.39 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Feb 2025 |
| Margin Keuntungan | -36.20% |
| Margin Operasi (TTM) | -39.67% |
| EPS Cair (TTM) | -1.69 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 55.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 21.02% |
| Nisbah Semasa (MRQ) | 8.95 |
| Aliran Tunai Operasi (OCF TTM) | -99.21 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -78.24 M |
| Pulangan Atas Aset (ROA TTM) | -13.36% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.62% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | PROCEPT BioRobotics Corporation | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 4.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 2.0 |
| Purata | 3.00 |
|
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 4.65% |
| % Dimiliki oleh Institusi | 91.09% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 84.00 (B of A Securities, 57.79%) | Beli |
| Median | 77.00 (44.64%) | |
| Rendah | 70.00 (Truist Securities, 31.49%) | Beli |
| Purata | 77.00 (44.64%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 52.28 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| B of A Securities | 25 Apr 2025 | 84.00 (57.79%) | Beli | 52.49 |
| Truist Securities | 11 Apr 2025 | 70.00 (31.49%) | Beli | 52.07 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 29 Apr 2025 | Pengumuman | PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June |
| 24 Apr 2025 | Pengumuman | PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance |
| 24 Apr 2025 | Pengumuman | PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops |
| 10 Apr 2025 | Pengumuman | PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas |
| 24 Mar 2025 | Pengumuman | WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation |
| 14 Mar 2025 | Pengumuman | PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |